B
Bo Lu
Researcher at Ohio State University
Publications - 390
Citations - 24905
Bo Lu is an academic researcher from Ohio State University. The author has contributed to research in topics: Cancer & Lung cancer. The author has an hindex of 58, co-authored 353 publications receiving 21823 citations. Previous affiliations of Bo Lu include Wuhan University of Technology & Wuhan University.
Papers
More filters
Journal ArticleDOI
Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Daniel E. Spratt,Roberto Diaz,James McElmurray,Ildiko Csiki,Dennis M. Duggan,Bo Lu,Dominique Delbeke +6 more
TL;DR: Evaluating the influence and accuracy of FDG PET in GTV definition as a complementary modality to CT for patients with non–small-cell lung carcinoma at Vanderbilt University Medical Center shows results consistent with the published data of PET/CT altering GTV in a significant number of patients.
Journal ArticleDOI
Clusterin as a therapeutic target for radiation sensitization in a lung cancer model
Carolyn Cao,Eric T. Shinohara,Hecheng Li,Ken Niermann,Kwang Woon Kim,Konjeti R. Sekhar,Martin E. Gleave,Martin E. Gleave,Michael L. Freeman,Bo Lu +9 more
TL;DR: A combination of radiotherapy and OGX-011 improved control of tumor growth and vascular regression in the H460 lung cancer model, and inhibition of clusterin followed by radiation greatly decreased cell survival.
Journal ArticleDOI
The impact of ‘social determinants of health’ on epilepsy prevalence and reported medication use
TL;DR: People with a history of epilepsy in poverty were significantly less likely than those not in poverty to report taking medication for epilepsy once material factors and healthcare access were controlled for in the final sequential model.
Journal ArticleDOI
The role of mTOR inhibition in augmenting radiation induced autophagy.
TL;DR: Current investigations of mTOR inhibitors in combination with radiation appear to potentiate radiation's ability to induce autophagy, which would represent an excellent therapeutic target as it would limit cell growth, decrease cell proliferation, and boost autophagocytosis.
Journal ArticleDOI
Understanding Tobacco Use Onset Among African Americans.
TL;DR: Late-onset smoking is not only the norm among African American adult smokers, but that late- versus early-ONSet smoking does not appear to afford any benefits for African Americans in terms of cessation or mortality, and prevention and intervention efforts need to consider individual groups.